LDL apheresis activates the complement system and the cytokine network, whereas PCSK9 inhibition with evolocumab induces no inflammatory response
Lappegård, Knut Tore, MD, PhD, Enebakk, Terje, RN, Thunhaug, Hilde, RN, Ludviksen, BSc, Judith Krey, Mollnes, Tom Eirik, MD, PhD, Hovland, Anders, MD, PhD
Published in Journal of clinical lipidology (01.11.2016)
Published in Journal of clinical lipidology (01.11.2016)
Get full text
Journal Article